Munafa Stock Market Course + Intraday & FNO calls 
Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for NASDAQ stock SUPN Supernus Pharmaceuticals. Dated: 13 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 48.09 and Closed at: 47.35, which is -2.32% of previous session's close. It moved within a range of 46.91 and 48.24
The session was a Bearish session with an average volume of 685200, which is -0.63% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
A Golden cross was found 3 days back on mid term averages
Support for tomorrow is 46.47 and resistance for tomorrow is 47.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 46.76, 46.17 resistance for tomorrow's hourly charts is 48.09, 48.83
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 47.9 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 46.22 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 47.23 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 49.21 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 49.12 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 46.22 and 200 DMA is at 49.12, while 50 DMA and 100 DMA are at 47.23 and 49.21 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 46.22 and 20 EMA is at 47.07
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Jul | 47.35 | 46.22 | 47.07 |
| 10 Fri Jul | 48.45 | 46.13 | 47.04 |
| 09 Thu Jul | 48.75 | 45.97 | 46.89 |
| 08 Wed Jul | 50.46 | 45.81 | 46.69 |
| 07 Tue Jul | 47.94 | 45.51 | 46.29 |
| 06 Mon Jul | 47.24 | 45.35 | 46.12 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 47.23 and 50 EMA is at 47.28
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Jul | 47.35 | 47.23 | 47.28 |
| 10 Fri Jul | 48.45 | 47.24 | 47.28 |
| 09 Thu Jul | 48.75 | 47.24 | 47.23 |
| 08 Wed Jul | 50.46 | 47.24 | 47.17 |
| 07 Tue Jul | 47.94 | 47.22 | 47.04 |
| 06 Mon Jul | 47.24 | 47.26 | 47 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 49.21 and 100 EMA is at 47.98
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Jul | 47.35 | 49.21 | 47.98 |
| 10 Fri Jul | 48.45 | 49.25 | 47.99 |
| 09 Thu Jul | 48.75 | 49.27 | 47.98 |
| 08 Wed Jul | 50.46 | 49.29 | 47.96 |
| 07 Tue Jul | 47.94 | 49.29 | 47.91 |
| 06 Mon Jul | 47.24 | 49.32 | 47.91 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 49.12 and 200 EMA is at 46.98
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Jul | 47.35 | 49.12 | 46.98 |
| 10 Fri Jul | 48.45 | 49.12 | 46.98 |
| 09 Thu Jul | 48.75 | 49.11 | 46.97 |
| 08 Wed Jul | 50.46 | 49.1 | 46.95 |
| 07 Tue Jul | 47.94 | 49.08 | 46.91 |
| 06 Mon Jul | 47.24 | 49.07 | 46.9 |
Xenon Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 23.36% more returns!
Vertex Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 1.32% more returns!
Vericel Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Vericel Corporation, about 20.16% more returns!
Supernus Pharmaceuticals has performed better than Sutro Biopharma in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Rockwell Medical has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Rockwell Medical, about 807.9% more returns!
Rocket Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Rocket Pharmaceuticals, about 28.65% more returns!
Pulmatrix Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 12.67% more returns!
Puma Biotechnology has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Puma Biotechnology, about 3.61% more returns!
Supernus Pharmaceuticals has performed better than Organogenesis Holdings in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Mustang Bio in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Catalyst Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Cytosorbents Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Editas Medicine has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Editas Medicine, about 19.78% more returns!
Fennec Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 12.82% more returns!
Icon Plc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Icon Plc, about 7.01% more returns!
Inc Research has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Inc Research, about 2.58% more returns!
Inmune Bio has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Inmune Bio, about 43.38% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term and the buy signal is strong.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.86 and Supernus Pharmaceuticals SUPN stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
